Mabwell Biotech Funding: $300M Raised, Series A (2020)
Mabwell Biotech is based in Shanghai, China. It has raised $300M in total funding. Latest round: Series A.
Mabwell Biotech funding overview
Mabwell Biotech is based in Shanghai, China. Mabwell Biotech has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in April 2020. The round record for Mabwell Biotech runs through 2020; nothing later has been disclosed. Investors on record include Shiyu Capital, Oriental Fortune Capital, Loyal Valley Capital, Haitong Capital, Founder H Fund, Ganzhou Development Investment Fund and 6 others. 12 distinct backers are named across the disclosed rounds.
Mabwell Biotech at a glance
Total raised
$300M
Latest round
Series A
Latest round date
April 2020
Headquarters
Shanghai, China
Notable investors
Shiyu Capital, Oriental Fortune Capital, Loyal Valley Capital, Haitong Capital, Founder H Fund, Ganzhou Development Investment Fund, Huarong Rongde Asset Management, Golden China Fund
Frequently asked about Mabwell Biotech funding
How much has Mabwell Biotech raised?
Mabwell Biotech has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Mabwell Biotech?
Shiyu Capital, Oriental Fortune Capital, Loyal Valley Capital, Haitong Capital, Founder H Fund, Ganzhou Development Investment Fund are named among the investors backing Mabwell Biotech.
What was the latest Mabwell Biotech funding round?
The most recent disclosed round is a Series A, announced in April 2020.
Where is Mabwell Biotech based?
Mabwell Biotech is based in Shanghai, China.
When did Mabwell Biotech last raise?
The last disclosed Mabwell Biotech round closed in April 2020 at Series A.
Mabwell Biotech totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.
